This contract expires in 177 days (Dec 31, 2026).
AKINA, INC. - THIS IS A FIRM FIXED PRICE FORNEW PLGA ANALYTICAL METHODS FOR MINI-SIZE COMPLEX LONG-ACTING INJECTABLE FORMULATIONS.
Key Details
Description
THIS IS A FIRM FIXED PRICE FORNEW PLGA ANALYTICAL METHODS FOR MINI-SIZE COMPLEX LONG-ACTING INJECTABLE FORMULATIONS.
Context & Analysis
On Dec 22, 2025, Department of Health and Human Services obligated $1,211,682 to AKINA, INC. for this is a firm fixed price fornew plga analytical methods for mini-size complex long-acting injectable formulations.. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in WEST LAFAYETTE, IN. The contract is scheduled through Dec 31, 2026 — approximately 6 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.